Article Type
Changed
Fri, 06/09/2023 - 11:29

Key clinical point: This meta-analysis demonstrated a significant bidirectional association between psoriasis and migraine, with greater severity of psoriasis being associated with an increasingly higher risk of developing migraine.

 

Major finding: Presence vs absence of psoriasis was associated with 1.69-fold higher odds of prevalent migraine (pooled odds ratio [OR] 1.69; 95% CI 1.26-2.28), with the risk for incident migraine being significantly higher in patients with mild (incidence rate ratio [IRR] 1.37; 95% CI 1.30-1.44) and severe (IRR 1.55; 95% CI 1.29-1.86) psoriasis and psoriatic arthritis (IRR 1.92; 95% CI 1.65-2.23). Moreover, presence vs absence of migraine was associated with 1.88-fold higher odds of prevalent psoriasis (OR 1.88; 95% CI 1.32-3.67).

 

Study details: Findings are from a systematic review and meta-analysis of 10 studies including 6,745,968 participants.

 

Disclosures: This study did not declare the funding source. The authors declared no conflicts of interest.

 

Source: Huang IH et al. Bidirectional associations between psoriasis and migraine: A systematic review and meta-analysis. J Dtsch Dermatol Ges. 2023;21(5):493-502 (Apr 17). doi: 10.1111/ddg.14994

Publications
Topics
Sections

Key clinical point: This meta-analysis demonstrated a significant bidirectional association between psoriasis and migraine, with greater severity of psoriasis being associated with an increasingly higher risk of developing migraine.

 

Major finding: Presence vs absence of psoriasis was associated with 1.69-fold higher odds of prevalent migraine (pooled odds ratio [OR] 1.69; 95% CI 1.26-2.28), with the risk for incident migraine being significantly higher in patients with mild (incidence rate ratio [IRR] 1.37; 95% CI 1.30-1.44) and severe (IRR 1.55; 95% CI 1.29-1.86) psoriasis and psoriatic arthritis (IRR 1.92; 95% CI 1.65-2.23). Moreover, presence vs absence of migraine was associated with 1.88-fold higher odds of prevalent psoriasis (OR 1.88; 95% CI 1.32-3.67).

 

Study details: Findings are from a systematic review and meta-analysis of 10 studies including 6,745,968 participants.

 

Disclosures: This study did not declare the funding source. The authors declared no conflicts of interest.

 

Source: Huang IH et al. Bidirectional associations between psoriasis and migraine: A systematic review and meta-analysis. J Dtsch Dermatol Ges. 2023;21(5):493-502 (Apr 17). doi: 10.1111/ddg.14994

Key clinical point: This meta-analysis demonstrated a significant bidirectional association between psoriasis and migraine, with greater severity of psoriasis being associated with an increasingly higher risk of developing migraine.

 

Major finding: Presence vs absence of psoriasis was associated with 1.69-fold higher odds of prevalent migraine (pooled odds ratio [OR] 1.69; 95% CI 1.26-2.28), with the risk for incident migraine being significantly higher in patients with mild (incidence rate ratio [IRR] 1.37; 95% CI 1.30-1.44) and severe (IRR 1.55; 95% CI 1.29-1.86) psoriasis and psoriatic arthritis (IRR 1.92; 95% CI 1.65-2.23). Moreover, presence vs absence of migraine was associated with 1.88-fold higher odds of prevalent psoriasis (OR 1.88; 95% CI 1.32-3.67).

 

Study details: Findings are from a systematic review and meta-analysis of 10 studies including 6,745,968 participants.

 

Disclosures: This study did not declare the funding source. The authors declared no conflicts of interest.

 

Source: Huang IH et al. Bidirectional associations between psoriasis and migraine: A systematic review and meta-analysis. J Dtsch Dermatol Ges. 2023;21(5):493-502 (Apr 17). doi: 10.1111/ddg.14994

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Migraine ICYMI, June 2023
Gate On Date
Tue, 01/11/2022 - 20:45
Un-Gate On Date
Tue, 01/11/2022 - 20:45
Use ProPublica
CFC Schedule Remove Status
Tue, 01/11/2022 - 20:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Activity Salesforce Deliverable ID
364621.3
Activity ID
92996
Product Name
Clinical Briefings ICYMI
Product ID
112
Supporter Name /ID
Nurtec ODT (rimegepant) [ 5341 ]